EHTH vs. MMC, AON, AJG, BRO, SLQT, WDH, TWFG, GOCO, RDZN, and ZBAO
Should you be buying eHealth stock or one of its competitors? The main competitors of eHealth include Marsh & McLennan Companies (MMC), AON (AON), Arthur J. Gallagher & Co. (AJG), Brown & Brown (BRO), SelectQuote (SLQT), Waterdrop (WDH), TWFG (TWFG), GoHealth (GOCO), Roadzen (RDZN), and Zhibao Technology (ZBAO). These companies are all part of the "insurance agents, brokers, & service" industry.
eHealth vs.
Marsh & McLennan Companies (NYSE:MMC) and eHealth (NASDAQ:EHTH) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, community ranking, institutional ownership and dividends.
88.0% of Marsh & McLennan Companies shares are owned by institutional investors. Comparatively, 79.5% of eHealth shares are owned by institutional investors. 0.3% of Marsh & McLennan Companies shares are owned by insiders. Comparatively, 4.1% of eHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Marsh & McLennan Companies has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, eHealth has a beta of 0.32, suggesting that its stock price is 68% less volatile than the S&P 500.
Marsh & McLennan Companies has higher revenue and earnings than eHealth. eHealth is trading at a lower price-to-earnings ratio than Marsh & McLennan Companies, indicating that it is currently the more affordable of the two stocks.
Marsh & McLennan Companies has a net margin of 16.60% compared to eHealth's net margin of -7.58%. Marsh & McLennan Companies' return on equity of 32.60% beat eHealth's return on equity.
Marsh & McLennan Companies received 23 more outperform votes than eHealth when rated by MarketBeat users. However, 61.76% of users gave eHealth an outperform vote while only 61.56% of users gave Marsh & McLennan Companies an outperform vote.
In the previous week, Marsh & McLennan Companies had 36 more articles in the media than eHealth. MarketBeat recorded 37 mentions for Marsh & McLennan Companies and 1 mentions for eHealth. Marsh & McLennan Companies' average media sentiment score of 1.48 beat eHealth's score of 0.00 indicating that Marsh & McLennan Companies is being referred to more favorably in the media.
Marsh & McLennan Companies currently has a consensus target price of $230.44, indicating a potential upside of 0.17%. eHealth has a consensus target price of $6.38, indicating a potential downside of 36.57%. Given Marsh & McLennan Companies' higher possible upside, equities research analysts clearly believe Marsh & McLennan Companies is more favorable than eHealth.
Summary
Marsh & McLennan Companies beats eHealth on 14 of the 17 factors compared between the two stocks.
Get eHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:EHTH) was last updated on 2/22/2025 by MarketBeat.com Staff
